IP Library › Patent Application 17226692
Patent Application
App. No. 17/226,692

METHODS AND DEVICES FOR DELIVERING CANCER THERAPY TO A TARGET TISSUE SITE VIA A CORED TISSUE CAVITY

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/226,692
Abstract

A method for delivering cancer therapy may comprise introducing a tissue resection device to the tissue site, using the tissue resection device to create a core of tissue, removing at least a portion of the core of tissue from the body to create a tissue cavity, and performing therapeutic management of malignant tissue via the tissue cavity.

Claims (43)

1 . A method for delivering therapy, the method comprising:

introducing a tissue resection device to a tissue site;

using the tissue resection device to create a core of tissue;

removing at least a portion of the core of tissue from the body to create a tissue cavity; and

performing therapeutic management of target tissue via the tissue cavity.

2 . The method of claim 1 , wherein the core of tissue comprises at least a portion of a tissue lesion.

3 . The method of claim 1 , wherein the target tissue comprises benign tissue.

4 . The method of claim 1 , wherein the target tissue comprises malignant tissue.

5 . The method of claim 1 , wherein the performing therapeutic management of tissue comprises ablation.

6 . The method of claim 1 , wherein the performing therapeutic management of tissue comprises chemotherapy.

7 . The method of claim 1 , wherein the performing therapeutic management of tissue comprises hydrogel-based controlled drug delivery.

8 . The method of claim 1 , wherein the performing therapeutic management of tissue comprises photodynamic therapy.

9 . The method of claim 1 , wherein the performing therapeutic management of tissue comprises using a scaffold system.

10 . The method of claim 1 , wherein the performing therapeutic management of tissue comprises hyperthermia of cored tissue site.

11 . The method of claim 1 , wherein the performing therapeutic management of tissue comprises:

disposing an energy delivery device into the tissue cavity; and

causing energy to be delivered to at least the target tissue.

12 . The method of claim 11 , wherein the energy delivery device comprises an inflatable balloon.

13 . The method of claim 11 , wherein the energy comprises radiofrequency energy.

14 . The method of claim 11 , wherein the energy comprises thermal energy.

15 . The method of claim 11 , wherein the energy delivery device comprises a microwave probe.

16 . The method of claim 11 , wherein the energy delivery device comprises a sleeve or port.

17 . The method of claim 1 , further comprising:

determining the existence of additional target tissue; and

removing at least a portion of the additional target tissue.

18 . A method for delivering therapy, the method comprising:

introducing an energy delivery device into a cored tissue cavity; and

performing therapeutic management of malignant tissue via the tissue cavity.

19 . The method of claim 18 , wherein the cored tissue comprises at least a portion of a tissue lesion.

20 . The method of claim 18 , wherein the performing therapeutic management of malignant tissue comprises ablation.

21 . The method of claim 18 , wherein the performing therapeutic management of malignant tissue comprises chemotherapy.

22 . The method of claim 18 , wherein the performing therapeutic management of malignant tissue comprises hydrogel-based controlled drug delivery.

23 . The method of claim 18 , wherein the performing therapeutic management of malignant tissue comprises photodynamic therapy.

24 . The method of claim 18 , wherein the performing therapeutic management of malignant tissue comprises using a scaffold system.

25 . The method of claim 18 , wherein the performing therapeutic management of malignant tissue comprises hyperthermia of cored tissue site.

26 . The method of claim 18 , wherein the energy delivery device comprises an inflatable balloon.

27 . The method of claim 18 , wherein the energy comprises radiofrequency energy.

28 . The method of claim 18 , wherein the energy comprises thermal energy.

29 . The method of claim 18 , wherein the energy delivery device comprises a microwave probe.

30 . The method of claim 18 , wherein the energy delivery device comprises a sleeve or port.

31 . The method of claim 18 , further comprising:

determining the existence of additional malignant tissue; and

removing at least a portion of the additional malignant tissue.

Assignments (2)
NUNC PRO TUNC ASSIGNMENT Recorded Jan 29, 2026
From: COHN, WILLIAM; DAGLOW, TERRY; KUHN, MATTHEW; NGUYEN, STEVEN; MILLER, SINEAD EMILY; MILLS, CHRIS
To: ETHICON, INC.
Reel/Frame 074535/0558 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2022
From: ETHICON, INC.
To: PRANA THORACIC, INC.
Reel/Frame 061820/0056 →